Follow the Indegene Limited share price and the full insider trade history of the company, a listed equity based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Indegene Limited has recorded 21 insider filings. Market capitalisation: €132.3bn. The latest transaction was disclosed on 20 March 2026 (Purchase). Among the most active insiders: BINA PATIL. The full history is openly available.
21
Insider Decl.
n/a
Thresholds
€1m
6 ops.
Buy Volume
€1m
15 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Indegene Limited Buy (bullish), based on 8 analysts. Average price target: ₹620.63.
24Σ signal
Buys €1m€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,198 of 29,062 companies
62.3
score / 100
Value
46
Quality
78
FCF yld4.6%
Earn yld3.0%
EV/EBITDA20.0x
ROE14%
Gross mgn·
Net mgn11%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
49,380 shares@ ₹669.399698.8% of flowEquity SharesSEBI:179d16bf7f9abcf550fe075526dd28d62d1bb0e4
21 of 21 declarations
About Indegene Limited
Indegene Limited is a company focused on healthcare and pharmaceutical solutions, providing technology and marketing services. It operates in the XBOM market.